Go to main content
Tricals - The highway towards a cure

Trial overview

Clinical trials are needed to find a cure for ALS. TRICALS supports multiple clinical trials. View the clinical trial overview to see current and past trials.

Find a Trial

Results

Archived

TUDCA-ALS

Phase 3
IIT
No

This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.

More about this trial

Archived

PHOENIX

Phase 3
Industry
No

Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035'.

More about this trial

Archived

CardinALS

Phase 2
Industry
No

The CARDINALS clinical research study is evaluating a study drug (Utreloxastat) to see if it can help slow ALS symptoms.

More about this trial

Archived

ADORE

Phase 3
Industry
No

Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of FNP122 for people with ALS.

More about this trial

Archived

VALOR

Phase 3
Industry
SOD1

Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with ALS.

More about this trial

Do you have questions about clinical trials?

Archived

RT001 trial

Phase 2
Industry
No

In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS.

More about this trial

Archived

ALSpire

Phase 1
Industry
No

This phase 1 clinical trial is evaluating the safety, tolerability & pharmacokinetics of the drug ‘BIIB105’ in people living with ALS.

More about this trial

Archived

APL2-ALS-206 trial

Phase 2
Industry
No

In this phase 2 study, we are investigating the safety and efficacy of the drug pegcetacoplan for the treatment of ALS.

More about this trial

Archived

COURAGE-ALS

Phase 3
Industry
No

In the COURAGE-ALS study, we are investigating the efficacy and safety of the drug ‘reldesemtiv’ for the treatment of ALS.

More about this trial

Archived

ALXN1210-ALS-308 trial

Phase 3
Industry
No

This study is designed to test the efficacy and safety of intravenous Ravulizumab in patients with ALS.

More about this trial
Previous page12
The TRICALS Registry

Register as a patient

Want to be notified by new clinical trials in your country? Register in the TRICALS registry and help us to get more people with ALS into a clinical trials.

Register